AXON
Price
$735.70
Change
+$26.44 (+3.73%)
Updated
Jul 25, 04:00 PM (EDT)
Capitalization
55.22B
10 days until earnings call
CRMD
Price
$11.72
Change
+$0.22 (+1.91%)
Updated
Jul 25, 01:07 PM (EDT)
Capitalization
864.87M
13 days until earnings call
Interact to see
Advertisement

AXON vs CRMD

Header iconAXON vs CRMD Comparison
Open Charts AXON vs CRMDBanner chart's image
Axon Enterprise
Price$735.70
Change+$26.44 (+3.73%)
Volume$400
Capitalization55.22B
CorMedix
Price$11.72
Change+$0.22 (+1.91%)
Volume$1.12K
Capitalization864.87M
AXON vs CRMD Comparison Chart in %
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. CRMD commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and CRMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (AXON: $709.26 vs. CRMD: $11.50)
Brand notoriety: AXON and CRMD are both not notable
AXON represents the Aerospace & Defense, while CRMD is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 193% vs. CRMD: 132%
Market capitalization -- AXON: $55.22B vs. CRMD: $864.87M
AXON [@Aerospace & Defense] is valued at $55.22B. CRMD’s [@Biotechnology] market capitalization is $864.87M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $284.21B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $20.73B. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 2 FA rating(s) are green whileCRMD’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 2 green, 3 red.
  • CRMD’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than CRMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while CRMD’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 5 bearish.
  • CRMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AXON is a better buy in the short-term than CRMD.

Price Growth

AXON (@Aerospace & Defense) experienced а -4.91% price change this week, while CRMD (@Biotechnology) price change was +3.88% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -1.09%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +43.67%.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.45%. For the same industry, the average monthly price growth was +19.48%, and the average quarterly price growth was +29.06%.

Reported Earning Dates

AXON is expected to report earnings on Nov 06, 2025.

CRMD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Aerospace & Defense (-1.09% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+8.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($55.2B) has a higher market cap than CRMD($865M). AXON has higher P/E ratio than CRMD: AXON (169.93) vs CRMD (46.00). CRMD YTD gains are higher at: 41.975 vs. AXON (19.340). AXON has higher annual earnings (EBITDA): 398M vs. CRMD (17.7M). AXON has more cash in the bank: 2.37B vs. CRMD (77.5M). CRMD has less debt than AXON: CRMD (477K) vs AXON (2.05B). AXON has higher revenues than CRMD: AXON (2.23B) vs CRMD (82.6M).
AXONCRMDAXON / CRMD
Capitalization55.2B865M6,382%
EBITDA398M17.7M2,249%
Gain YTD19.34041.97546%
P/E Ratio169.9346.00369%
Revenue2.23B82.6M2,695%
Total Cash2.37B77.5M3,054%
Total Debt2.05B477K429,140%
FUNDAMENTALS RATINGS
AXON vs CRMD: Fundamental Ratings
AXON
CRMD
OUTLOOK RATING
1..100
6352
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
1070
SMR RATING
1..100
5445
PRICE GROWTH RATING
1..100
4348
P/E GROWTH RATING
1..100
1156
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRMD's Valuation (76) in the Medical Specialties industry is in the same range as AXON (96) in the Biotechnology industry. This means that CRMD’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (10) in the Biotechnology industry is somewhat better than the same rating for CRMD (70) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than CRMD’s over the last 12 months.

CRMD's SMR Rating (45) in the Medical Specialties industry is in the same range as AXON (54) in the Biotechnology industry. This means that CRMD’s stock grew similarly to AXON’s over the last 12 months.

AXON's Price Growth Rating (43) in the Biotechnology industry is in the same range as CRMD (48) in the Medical Specialties industry. This means that AXON’s stock grew similarly to CRMD’s over the last 12 months.

AXON's P/E Growth Rating (11) in the Biotechnology industry is somewhat better than the same rating for CRMD (56) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than CRMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONCRMD
RSI
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 8 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBICX10.11N/A
N/A
ClearBridge International Value C
PRJCX40.70N/A
N/A
PGIM Jennison Global Opportunities C
RYLIX104.98N/A
N/A
Rydex Leisure Inv
SVOAX14.90N/A
N/A
SEI US Managed Volatility F (SIMT)
IUEFX29.03-0.24
-0.82%
JPMorgan International Focus R5

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-1.03%
MURA - CRMD
38%
Loosely correlated
+0.41%
ARTL - CRMD
33%
Poorly correlated
-6.65%
RLYB - CRMD
32%
Poorly correlated
-0.95%
XLO - CRMD
31%
Poorly correlated
+0.09%
AXON - CRMD
30%
Poorly correlated
+0.57%
More